BioNexus Gene Lab Corp. (BGLC)

OTCMKTS: BGLC · Delayed Price · USD
0.706
+0.006 (0.86%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Market Cap 12.79M
Revenue (ttm) 10.34M
Net Income (ttm) -3.09M
Shares Out 17.79M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 76,305
Open 0.660
Previous Close 0.700
Day's Range 0.660 - 0.720
52-Week Range 0.080 - 9.490
Beta 1.91
Analysts n/a
Price Target n/a
Earnings Date n/a

About BGLC

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incor... [Read more]

Sector Healthcare
Founded 2017
Employees 27
Stock Exchange OTCMKTS
Ticker Symbol BGLC
Full Company Profile

Financial Performance

Financial Statements

News

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw materials in...

8 months ago - GlobeNewsWire

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

KUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”), an emerging company in the business of selling chemical raw materials in the Southeast ...

9 months ago - GlobeNewsWire